Abstract
Purpose
To define the clinical presentation of aerococcal infective endocarditis (IE) and the prevalence of synergy between penicillin and gentamicin on aerococcal isolates.
Methods
Cases of aerococcal IE between 2002 and 2014 were identified in the Swedish Registry of Infective Endocarditis (SRIE). MALDI-TOF MS was used to confirm species determination. The medical records were analysed and compared to cases reported to the SRIE caused by other pathogens.
Results
Sixteen cases of aerococcal IE, fourteen with Aerococcus urinae and two with Aerococcus sanguinicola, were confirmed. Etest-based methods and time-kill experiments suggested synergy between penicillin and gentamicin towards seven of fifteen isolates. The patients with aerococcal IE were significantly older than those with streptococci or Staphylococcus aureus IE. Most of the patients had underlying urinary tract diseases or symptoms suggesting a urinary tract focus of the infection. Seven patients with aerococcal IE presented with severe sepsis but ICU treatment was needed only in one patient and there was no fatality. Valve exchange surgery was needed in four patients and embolization was seen in three patients.
Conclusions
This report is the largest on aerococcal IE and suggests that the prognosis is relatively favourable despite the fact that the patients are old and have significant comorbidities.
Similar content being viewed by others
References
Parker MT, Ball LC. Streptococci and aerococci associated with systemic infection in man. J Med Microbiol. 1976;9:275–302.
Rasmussen M. Aerococci and aerococcal infections. J Infect. 2012;6:467–474.
Cattoir V, Kobal A, Legrand P. Aerococcus urinae and Aerococcus sanguinicola, two frequently misidentified uropathogens. Scand J Infect Dis. 2010;42:775–80.
Senneby E, Nilson B, Petersson AC, Rasmussen M. Matrix-assisted laser desorption ionization-time of flight mass spectrometry is a sensitive and specific method for identification of aerococci. J Clin Microbiol. 2013;51:1303–4.
Christensen JJ, Dargis R, Hammer M, Justesen US, Nielsen XC, Kemp M, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis of Gram-positive, catalase-negative cocci not belonging to the Streptococcus or Enterococcus genus and benefits of database extension. J Clin Microbiol. 2012;50:1787–91.
Christensen JJ, Jensen IP, Faerk J, Kristensen B, Skov R, Korner B. Bacteremia/septicemia due to Aerococcus-like organisms: report of seventeen cases. Danish ALO Study Group. Clin Infect Dis. 1995;21:943–7.
Senneby E, Petersson AC, Rasmussen M. Clinical and microbiological features of bacteraemia with Aerococcus urinae. Clin Microbiol Infect. 2012;18:546–50.
de Jong MFC, Soetekouw R, ten Kate RW, Veenendaal D. Aerococcus urinae: severe and fatal bloodstream infections and endocarditis. J Clin Microbiol. 2010;48:3445–7.
Ibler K, Truberg Jensen K, Ostergaard C, Sönksen UW, Bruun B, Schønheyder HC, et al. Six cases of Aerococcus sanguinicola infection: clinical relevance and bacterial identification. Scand J Infect Dis. 2008;40:761–5.
Senneby E, Eriksson B, Fagerholm E, Rasmussen M. Bacteremia with Aerococcus sanguinicola: case series with characterization of virulence properties. Open Forum Infect Dis. 2014;1:ofu025.
Williams RE, Hirch A, Cowan ST. Aerococcus, a new bacterial genus. J Gen Microbiol. 1953;8:475–80.
Rasmussen M. Aerococcus viridans is not a matter of opinion. Comment on: an unusual microorganism, Aerococcus viridans, causing endocarditis and aortic valvular obstruction due to a huge vegetation (Turk Kardiyol Dern Ars 2011;39:317-319). Turk Kardiyol Dern Ars. 2012;40:112.
Christensen JJ, Vibits H, Ursing J, Korner B. Aerococcus-like organism, a newly recognized potential urinary tract pathogen. J Clin Microbiol. 1991;29:1049–53.
Sierra-Hoffman M, Watkins K, Jinadatha C, Fader R, Carpenter JL. Clinical significance of Aerococcus urinae: a retrospective review. Diagn Microbiol Infect Dis. 2005;53:289–92.
Schuur PM, Kasteren ME, Sabbe L, Vos MC, Janssens MM, Buiting AG. Urinary tract infections with Aerococcus urinae in the south of The Netherlands. Eur J Clin Microbiol Infect Dis. 1997;16:871–5.
Shelton-Dodge K, Vetter EA, Kohner PC, Nyre LM, Patel R. Clinical significance and antimicrobial susceptibilities of Aerococcus sanguinicola and Aerococcus urinae. Diagn Microbiol Infect Dis. 2011;70:448–51.
Senneby E, Petersson AC, Rasmussen M. Epidemiology and antibiotic susceptibility of aerococci in urinary cultures. Diagn Microbiol Infect Dis. 2015;81:149–51.
Rasmussen M. Which Aerococcus? comment on: an unusual microorganism, Aerococcus viridans, causing endocarditis and aortic valvular obstruction due to a huge vegetation (turk kardiyol dern ars 2011;39:317-9). Turk Kardiyol Dern Ars. 2011;39:630.
Chen L-Y, Yu W-C, Huang S-H, Lin M-L, Chen T-L, Fung C-P, et al. Successful treatment of Aerococcus viridans endocarditis in a patient allergic to penicillin. J Microbiol Immunol Infect. 2012;45:158–60.
Skov R, Christensen JJ, Korner B, Frimodt-Møller N, Espersen F. In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. J Antimicrob Chemother. 2001;48:653–8.
Zbinden R, Santanam P, Hunziker L, Leuzinger B, von Graevenitz A. Endocarditis due to Aerococcus urinae: diagnostic tests, fatty acid composition and killing kinetics. Infection. 1999;27:122–4.
Ternhag A, Cederström A, Törner A, Westling K. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One. 2013;8:e67519.
Matuschek E, Brown DFJ, Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 2014;20:O255–66.
Pankey GA, Ashcraft DS, Dornelles A. Comparison of 3 Etest(®) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species. Diagn Microbiol Infect Dis. 2013;77:220–6.
Weinstein AJ, Moellering RC. Studies of cephalothin: aminoglycoside synergism against enterococci. Antimicrob Agents Chemother. 1975;7:522–9.
Sunnerhagen T, Hammarlund P, Rasmussen M. A case of suspected infective endocarditis with Lactococcus garvieae: lack of in vitro synergy between ampicillin and gentamicin. JMM Case Rep. 2015;2(1):e000018. doi:10.1099/jmmcr.0.000018.
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200–9.
Rasmussen M. Aerococci: hard to find and classify. Rev Argent Microbiol. 2011;43:312 (authorreply312–3).
Acknowledgments
This work was supported by the Swedish Government Fund for Clinical Research (ALF), the Royal Physiographic Society in Lund, and the foundations of Marianne and Marcus Wallenberg, Groschinski, Crafoord, and Österlund. Dr Malin Inghammar is acknowledged for important discussions. The authors acknowledge the kind help from all participating clinical microbiology laboratories and infectious diseases clinics. The authors have no conflicting interests to declare. Part of this work was presented at the ISCVID 2013 congress, Dubrovnik, Croatia.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Sunnerhagen, T., Nilson, B., Olaison, L. et al. Clinical and microbiological features of infective endocarditis caused by aerococci. Infection 44, 167–173 (2016). https://doi.org/10.1007/s15010-015-0812-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-015-0812-8